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Clinical appfications o f  biofeedback have proliferated and considerable lore 
surrounding the application of  these techniques has evolved. Many 
assertions about the effectiveness o f  biofeedback training are based on 
findings o f  the least well-controlled studies, while many o f  the better 
controlled studies have failed to show that biofeedback directly mediates 
target symptoms or is superior to other treatments. Steiner and Dince (1981) 
suggest that the failure of  these controlled studies is primarily attributable 
to methodological deficiencies. We believe that the question o f  whether or 
not there is a specific effect o f  biofeedback training is still frequently 
confused with the question o f  whether or not the treatment package as a 
whole has therapeutic value. Biofeedback is often therapeutic; however, 
evidence is often lacking that its effectiveness is due to biofeedback- 
trained changes in a target physiological process. 
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In a commentary by Steiner and Dince (1981), the authors criticized efficacy 
studies of  biofeedback techniques that have failed to show a specific or 
active effect of  biofeedback or superiority over other treatments. It is their 
contention that methodological deficiencies account for the fact that many 
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controlled studies have failed to demonstrate that biofeedback treatments 
directly mediate improvement of target symptoms or are superior to 
alternative treatments. 
While we support their view that better biofeedback efficacy studies 
are needed, we disagree with Steiner and Dince on many points. We are also 
perplexed by the theme of their paper, which supports the need for better 
research design yet levels strongest criticism at the more methodologically 
sophisticated studies. Ironically, the effect of their article can be interpreted 
as a defense of the results of methodologically inferior studies that form the 
basis of many claims about the efficacy of biofeedback. 
HISTORICAL PERSPECTIVE 
Steiner and Dince begin their paper with an attempt to place 
biofeedback in historical perspective. It is too early to write a definitive 
history, and alternatives to their perspective (e.g., Katkin, 1982) are 
possible. In our opinion, the field of biofeedback did not arise out of a 
search for methods to treat specific psychophysiological problems. The 
study of biofeedback applications was stimulated by research aimed at 
answering fundamental questions about whether or not the autonomic 
nervous system could be modified by instrumental learning. Miller's (1969) 
influential report summarized a series of animal studies that seemed to 
demonstrate the operant learning of several visceral responses. That same 
year Kamiya (1969) described his experiments on the operant control of 
EEG alpha in human subjects. 
Soon after these and similar reports were published, serious questions 
were raised about the findings and interpretations. Fourteen years later, we 
are still not certain that the autonomic nervous system is subject to 
instrumental learning without mediation by striate musculature. From a 
clinical point of view, we are still without definitive evidence that the 
autonomic nervous system can be altered to a clinically significant degree by 
means of biofeedback without mediation from a variety of confounding 
variables. 
Despite this shaky foundation of unreplicated early studies and 
unresolved theoretical issues, enthusiastic support and a large biofeedback 
industry composed of clinicians and equipment manufacturers has evolved 
and grown. Numerous reviews of the literature on biofeedback treatment 
have appeared recently (e.g., Jessup, Neufeld, & Merskey, 1979; Turner & 
Chapman, 1982). Some strongly suggest that biofeedback efficacy has been 
demonstrated only with respect to functions mediated by striate muscle. 
Even for these functions, there is uncertainty as to whether the efficacy of 
Reply to Steiner and Dince 489 
biofeedback exceeds that of relaxation training alone. Further, the 
operation of Roberts's Third Law (Roberts, 1982) would provide enough 
intermittent reinforcement for therapists to maintain their behavior with 
great resistance to extinction even in the absence of a specific treatment 
effect. 3 
EXPERIMENTAL METHOD 
Steiner and Dince appear to confuse the fundamental aims of 
scientific study with the fundamental aim of therapy. The purpose of 
scientific study is to apply the scientific method in order to understand, 
predict, and control observable phenomena. The primary purpose of 
therapy is to change the behavior of patients. Experiments need to be 
designed that delineate the essential ingredients in biofeedback treatment 
and how they can be manipulated most effectively in order to produce 
clinical change. Even when biofeedback efficacy studies have positive 
outcomes, they frequently do not address the issue of necessary and 
sufficient conditions. Is it feedback about changes in specific physiological 
processes, the therapeutic relationship, or some interaction between the two 
of these that mediates change? Would the outcomes be the same if an 
impressive machine with leads, electrodes, dials, sounds, and meters were 
substituted for the biofeedback equipment and everything else was held 
constant, including the therapist's and client's belief in the efficacy of the 
treatment? In a therapeutic relationship where biofeedback is only part of 
the treatment, there is no way to be certain if the biofeedback is either 
necessary or sufficient to accomplish the desired treatment outcome. 
As Steiner and Dince point out, "ignorance of a mechanism of action 
is not equal to lack of clinical efficacy" (p. 275). The demonstration of 
clinical efficacy, however, does not prove that biofeedback training of a 
target physiological process is either necessary or sufficient to mediate the 
clinical changes that may occur. It may not be necessary to understand 
exactly how changing a target process leads to improvement, but it is 
important to determine if the trained changes significantly contribute to the 
therapeutic effect obtained by the treatment package as a whole. 
Continuing to maintain that a particular physiological mechanism of 
therapeutic action in biofeedback training even exists, when you are unable 
3Roberts' Third Law was derived from studies and reports of treatments that were thought to 
be specific at the time they were published but that were later shown to be nonspecific. 
It states that if both the patient and the clinician believe in the efficacy of a treatment 
for a nonspecific disease, outcomes based upon nonspecific effects will approximate one- 
third "excellent" results, one-third "good," and one-third "poor" results. 
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to prove that it has a measureable effect in the first place, is more the 
province of faith than of science. 
The issue is not whether treatment with biofeedback is therapeutic. It 
is. The literature is replete with evidence that some patients treated for 
various problems with biofeedback improve. However, faith healing, 
acupuncture, electrical stimulation, psychotherapy, dream analysis, and 
placebo medications also improve symptoms. The task of the scientist is to 
understand how biofeedback works when it does work, and what will 
improve its efficacy. 
BIOFEEDBACK RESEARCH METHODOLOGY PROBLEMS 
We agree with Steiner and Dince that most biofeedback efficacy 
studies are not exemplary models of research. We also agree that it is 
important not to generalize uncritically about the biofeedback field as a 
whole. However, there are many methodological problems that are 
common to a number of different techniques. 
1. Baseline periods are too short or not used at all. Normal 
adaptational changes from the patient sitting quietly in a comfortable room 
are erroneously interpreted as evidence of biofeedback-trained control of 
the target response. 
2. Little or no attempt is made to preserve the diagnostic homogeneity 
of the study sample. 
3. There is no attempt to assess the quantitative relationship between 
amount of control of the target physiological process and symptom change. 
4. A mixture of treatments such as psychotherapy, EMG relaxation, 
autogenic training, relaxation training, or stress management instructions is 
administered to the patient in addition to biofeedback either deliberately or 
inadvertently (possibly as part of a warm, supportive therapist-patient rela- 
tionship). This obviously makes it impossible to determine which of the 
procedures introduced is responsible for the therapeutic benefit claimed. 
5. Inadequate control groups are used to assess the contributions of 
general relaxation, self-monitoring by keeping symptom diaries, patient 
expectation, different therapist behaviors or styles, variations in training 
procedures, passage of time, weather changes (e.g., see Guglielmi & 
Roberts, 1983), or other nonspecific effects that are likely to be significant. 
Variations in training procedures and the way the therapist functions 
were two issues highlighted by Steiner and Dince. 
Therapist Variables 
Steiner and Dince assert that the "expectations of the therapist" (p. 
280) or the ways in which the therapist acts (p. 279) affect the outcome of 
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biofeedback treatment. This is a reasonable assertion but it does not address 
the issue of the relative contribution of these variables to biofeedback 
training. Indeed, there are some biofeedback studies suggesting that a role 
can be played by nonspecific factors that outweigh a specific effect of 
control of the target physiologic process. For instance, Gauthier, Bois, 
Allaire, and Drolet (1981) compared cooling versus warming the finger and 
cooling versus warming the temporal artery as a biofeedback treatment for 
migraine headache. Andrasik and Holroyd (1980) trained three groups of 
tension headache patients either to increase, decrease, or hold stable their 
frontalis EMG. The results of these studies were similar to other well- 
controlled studies that have generally shown improvement in subjects 
irrespective of the direction of regulation. 
It is apparent that more work needs to be done to elucidate the non- 
specific effects contributing to biofeedback efficacy. This is more than the 
assertion that placebo or nonspecific effects exert real and measurable 
therapeutic changes. It is a proposal to direct some of our research effort 
toward making nonspecific factors "more specific" in order to use them 
even more efficaciously. Plotkin (1980) has suggested experimental designs 
for studying this issue and has hypothesized various factors that merit 
careful investigation. These include (1) attribution of responsibility, (2) 
provision for the opportunities to experience success, (3) face validity, and 
(4) high level of patient acceptance and interest. 
Steiner and Dince believe that untrained therapists are less effective 
than trained therapists. To support their statement, Steiner and Dince cited 
Taub and School (1978), which compared an impersonal therapist with a 
friendly and informal therapist. Friendliness, however, has no clear 
relationship to training. It is even conceivable that there is an inverse 
relationship between the degree of warmth or friendliness and the degree of 
training. The Biofeedback Society of America standards notwithstanding, 
there are no experimentally determined standards defining what skills or 
behaviors constitute adequate training. 
Interestingly, the issue of the possible negative impact of an 
impersonal or untrained therapist seems to arise only when the results of a 
study fail to show a specific change caused by biofeedback. Published 
studies with positive results have also utilized inexperienced personnel? In 
fact, the ability of untrained therapists to obtain positive results can be 
viewed as an advantage of biofeedback treatments. Steiner and Dince's 
4When Roberts, Kewman, and Macdonald (1973) demonstrated the ability of human subjects 
to differentially control peripheral skin temperature in their 1971 laboratory studies, the 
experimenters were untrained as "skin temperature biofeedback therapists." When their 
results were replicated (Roberts, Schuler, Bacon, Zimmerman, & Patterson, 1975), the subjects 
were run by two untrained students who nevertheless taught the subjects to control peripheral 
skin temperature. Cram (1980) also showed beneficial effects of  EMG biofeedback on tension 
headache using essentially untrained undergraduate therapists. 
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belief that "it is possible for the therapist to act in a manner that overrides 
the effects of biofeedback treatment" (p. 279) is only one possible rationale 
for treatment failures and has not yet been substantiated by research. 
Some researchers have begun to examine these issues. Blanchard et al. 
(1983) demonstrated that outcome from EMG biofeedback treatment for 
headache was not significantly related to the amount of experience of the 
therapist. They also showed that there was no significant relationship 
between outcome and the patient's perception of therapist competence, 
helpfulness, or warmth. Interestingly, they found a negative relationship 
between perceived warmth of the therapist and improvement, although this 
correlation did not quite reach significance (p < . 10). 
Hamberger and Lohr (1981) studied the effect of therapists' presence 
and response-contingent feedback in EMG biofeedback relaxation training. 
They found no difference between subjects who were trained with a 
therapist present and those who were trained alone in a more isolated 
environment. They concluded that a trainer's presence is not a crucial 
variable in facilitating subject-controlled, response-contingent relaxation 
training. Interestingly, the isolation of the subject from the "unblind" 
experimenter has been used as a criticism of the double-blind research 
design in biofeedback research. 
Training Procedures 
Steiner and Dince raised the issue of the relationship between adequate 
biofeedback training of the patient and the effectiveness of biofeedback 
treatment. They asserted that the administration of training is not equal to 
the subjects learning a biofeedback skill to criterion. This statement is a 
logical and common criticism of "unsuccessful" studies, but there is no 
experimentally validated training criterion for  most biofeedback 
techniques. It is important to note that no study has shown that reliable 
learning occurs either to the arbitrary criteria enunciated by Fahrion (1977) 
or to any other criterion. 
In the case of skin temperature, numerous studies have failed to 
validate voluntary vasodilation for both normal subjects and patients 
(Guglielmi, Roberts, & Patterson, 1982). Surwit (1978) concluded that "a 
review of the experimental literature produces only equivocal evidence for 
the ability of humans to learn to voluntarily vasodilate with the use of 
temperature feedback alone" (p. 10). 
When "learning" does not take place in the laboratory setting, one 
may reasonably question whether learning occurs in the clinical setting. If it 
really occurs in the latter and not in the former, is the learning due to the 
biofeedback, to the setting, or to some interaction? The assumption that 
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research studies are not "clinical" and that patients are treated differently in 
the laboratory by inadequately trained personnel is simply an assumption, 
and there is no evidence to support this. 
Steiner and Dince feel that in the training of a biofeedback task, one 
must specify the terminal behavior, provide the subject with an example of 
the task, give the subject a demonstration of the task, and provide 
instruction as to how someone might achieve that end. In fact, just the 
opposite may be true. The Task Force of the Biofeedback Society of 
America (Carlson, 1978) concludes their review of the experimental 
evidence concerning knowledge of the response by stating that "there 
appears to be no basis for the claim by many clinicians that awareness of the 
feedback-relevant response is necessary to achieve self-control over the 
response . . . .  [I]n fact, the weight of the evidence to date indicates that non- 
awareness produces results equal to or better than awareness" (p. 7). 
Steiner and Dince cited work suggesting that "eight to twenty-five 
hours of training have proven necessary for effective and lasting symptom 
alleviation" (p. 280). Stimulated by this contention, we decided to examine 
some previously unpublished follow-up data from a clinical biofeedback 
laboratory staffed by highly competent therapists meeting the standards for 
certification by the Biofeedback Society of America: The subjects were 55 
patients with medical diagnoses of migraine headaches and 72 patients with 
medical diagnoses of muscle contraction headaches. Three months to 1 year 
following completion of biofeedback treatment, the patients were contacted 
for follow-up data, which consisted in part of ratings of overall improve- 
ment from 0 ("none") to 4 ("complete"). Separate ratings of improvement 
were also obtained for changes in intensity, frequency, and duration of 
headaches, as well as reduction in the use of medication. 
These data were analyzed separately for the two kinds of headaches 
with respect to the number of biofeedback training sessions the patients 
completed before terminating therapy. For migraine headaches, the number 
of training sessions correlated - .02  with overall ratings of improvement 
and - . 20  with the number of categories of improvement. For muscle 
contraction headaches, the correlation was .02 for both overall ratings of 
improvement and the number of categories of improvement. 
The subjects in the two groups were also divided into those who rated 
their improvement as either "none," "some," or "moderate" (n = 39 for 
muscle contraction and n = 28 for migraines) and those who rated 
improvement as "considerable" or "complete" (n = 33 for muscle con- 
traction and n = 27 for migraines). For muscle contraction headaches the 
5We are greatful to Richard A. Sternbach for providing these data  f rom patients trei~.~'d in 
the clinical biofeedback laboratories of  the Scripps Clinic Pain Center, which he directs. 
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mean number of training sessions was 7.45 (SD = 1.93) for moderate or less 
improvement and 7.77 (SD = 2.34) for considerable or better 
improvement. These means are not significantly different from each other 
(t(70) = 1.370). For migraine headaches, the mean number of  training 
sessions was 7.61 (SD = 2.44) and 7.89 (SD = 2.26), respectively, for the 
two outcome groups. These means are also not significantly different (t(53) 
= 1.045). 
For this follow-up study, at least, we cannot demonstrate any 
relationship between hours of  training and effective and lasting symptom 
alleviation. Similarly, we are unaware of  any published studies that have 
conclusively shown a clear quantitative relationship between the magnitude 
of  control of physiological processes using biofeedback and degree of  
clinical improvement. 
INTERPRETATION OF EXPERIMEN TA L OUTCOMES 
Steiner and Dince have pointed out that the failure to find an effect in 
a research design is not the same as proving the absence of  an effect. 
However, the superiority of  biofeedback is not demonstrated if the effects 
of biofeedback are not significantly better than those obtained by control 
groups. 6 
Steiner and Dince understand this point because they invent an 
example of  a "new drug morphine," which is compared with a sterile water 
placebo. In their fictional example, the placebo group shows a large 
reduction in pain, and morphine is not significantly better than the 
placebo. 7 They suggest that one should not conclude that morphine lacks 
analgesic properties, but rather that "the placebo effect was so powerful 
that it was impossible to demonstrate morphine's analgesic effects" (p. 277). 
From their example it should be clear, however, that a difference that 
makes no difference is no difference at all. If  one can achieve results with 
6Two studies (Kewman & Roberts, 1980; Blanchard, Theobald, Williamson, Silver, & Brown, 
1978) were erroneously cited by Steiner and Dince (p. 279) as failing to demonstrate the 
effectiveness of  biofeedback. Blanchard et al., (1978) did show efficacy for biofeedback 
versus headache monitoring but failed to show its superiority over relaxation. Migraine 
patients receiving biofeedback in Kewman and Roberts (1980) also improved, but the specific 
therapeutic value of  increasing finger temperature was not shown. 
7Steiner and Dince's example is not too far-fetched. Recent studies (VanDyke & Bick, 1982) 
have shown that experienced users of  cocaine cannot differentiate it from cheaper, legal 
lidocaine, procaine, or placebo in a laboratory situation. Ironically, VanDyke and Bick con- 
clude their review with the statement that "many of  the questions surrounding the issue of  
cocaine can be answered by scientific investigation, but the final decisions about cocaine will 
be political and economic, not scientific" (p. 141). It is profoundly hoped that the same will 
not be true of  biofeedback. 
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placebo that are close to those one achieves with biofeedback, then the 
advantages of  biofeedback are only greater to the patient if it is more 
efficient and more economical, or if there are fewer side effects. 
Steiner and Dince criticize some of  the more powerful procedures for 
controlling for nonspecific effects in biofeedback treatment such as the 
double-blind design. It is true that a double-blind experimental design is not 
the only way to control for nonspecific effects, but it is one procedure that 
can be used to see if the specific effects of  a treatment are sufficiently 
powerful to show a difference over nonspecific factors. Studies that have 
used this or similar designs unfortunately have not been able to demonstrate 
a specific or superior effect of the biofeedback despite clinical improve- 
ment of  the patients treated. 
In discussing Type I and Type II statistical errors, one must realize 
that these issues are as applicable to clinical reports as they are to studies 
using group comparisons. The biofeedback literature contains numerous 
reports of positive outcomes with only a few subjects and no controls. The 
likelihood of  committing a Type I error is exceedingly high in these kinds of 
reports. The problem is further confounded by the fact that the negative 
results of  clinical or research studies are often not published. 
Steiner and Dince's suggestion for the use of  power analysis in future 
studies is a good one. When small numbers of subjects are used, it may also 
be helpful to use groups of  subjects who are matched according to initial 
baseline values or degree of learning of  the target skills. Furthermore, 
longer and better follow-up is needed. This may be particularly important in 
trying to determine if a specific effect of  biofeedback training may be more 
efficacious than the nonspecific effects because of  duration of  action. 
CONCLUSIONS 
As clinicians, we find it too easy to discount research findings that do 
not support our beliefs by viewing the studies as poor analogues to everyday 
clinical situations. Yet the major  difference between the clinical and 
laboratory setting is that the experimenters in the laboratory are carefully 
applying certain rules to the collection and analysis of  data. By doing this, 
they are avoiding the pitfall of  allowing fallible clinical judgments to 
supplant scientifically derived conclusions. 
As clinicians, we feel that there is nothing wrong with trying to help 
our clients with only partly understood treatment modalities. At the same 
time, it is important  to realize that a treatment may work for reasons other 
than the ones we believe in. It may also be true that some of  the things we 
believe in may be effective only because we believe in them. It is important 
to keep in mind that ethical guidelines for psychologists require us to 
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provide clients with a thorough discussion of the limitations of our data as 
well as to acknowledge the existence of other hypotheses and explanations 
(American Psychological Association, 1981). 
No single study or set of controls will provide the definitive answer 
regarding the therapeutic efficacy of biofeedback treatment. It is not 
necessary to argue that experimental studies are complete, perfect, or 
definitive. It is only necessary to point out that experimental studies attempt 
to control variables ignored or neglected by clinical reports or other studies 
and therefore add a dimension to knowledge and understanding. The 
challenge to biofeedback researchers is not to abandon controlled studies 
because of their inherent difficulties and limitations, but rather to carry out 
more sophisticated and better controlled experiments that will enhance our 
understanding of the phenomenon of biofeedback. 
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